Bank of America
NVNO

Bank of America’s enVVeno Medical NVNO Stock Holding History

Bank of America’s Portfolio NVNO Stock Details NVNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-58
Closed -$648 – 6514
2025
Q4 		$648 Buy
58
+57
+5,700% +$1.11K ﹤0.01% 6525
2025
Q3 		$18 Sell
1
-4
-80% -$409 ﹤0.01% 8173
2025
Q2 		$671 Buy
5
+1
+25% +$118 ﹤0.01% 7605
2025
Q1 		$394 Hold
4
– – ﹤0.01% 7560
2024
Q4 		$432 Buy
4
+1
+33% +$112 ﹤0.01% 7432
2024
Q3 		$366 Hold
3
– – ﹤0.01% 7443
2024
Q2 		$520 Buy
+3
New +$524 ﹤0.01% 7353
2024
Q1 		– Hold
0
– -$41 – 8052
2023
Q4 		– Hold
0
– – – 7535
2023
Q1 		– Hold
0
– -$51 – 8137
2022
Q4 		– Hold
0
– – – 7788
2022
Q1 		– Sell
-127
Closed -$29K – 8606
2021
Q4 		$29K Sell
127
-140
-52% -$39.4K ﹤0.01% 7410
2021
Q3 		$97K Buy
+267
New +$69.1K ﹤0.01% 6743
2021
Q1 		– Sell
-6
Closed -$2K – 7666
2020
Q4 		$2K Buy
+6
New +$1.86K ﹤0.01% 6948
2020
Q1 		– Sell
-10
Closed -$5K – 7119
2019
Q4 		$5K Buy
10
+8
+400% +$4.15K ﹤0.01% 6767
2019
Q3 		$2K Buy
+2
New +$1.74K ﹤0.01% 7006
2019
Q1 		– Hold
0
– – – 7321
2018
Q4 		– Hold
0
– – – 7289

Other funds holding NVNO

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America's NVNO Position: Q1 2026 in Review

Bank of America sold out of enVVeno Medical (NVNO) in Q1 2026, closing a stake of 58 shares — an estimated $648 sold.

Bank of America first reported a position in NVNO in Q3 2019 and held it in 12 quarters. The position peaked at $97K in Q3 2021. 17 funds tracked by Wall St. Rank hold NVNO as of Q1 2026.

  • Bank of America reported no remaining enVVeno Medical position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 58 enVVeno Medical shares in Q1 2026, an estimated $648.
  • Bank of America first reported a position in enVVeno Medical in Q3 2019 and held it in 12 quarters.
  • Bank of America's enVVeno Medical position peaked at $97K in Q3 2021.
  • 17 funds tracked by Wall St. Rank held enVVeno Medical as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.